Company Overview
Snapshot
Founded in January 2007 by Yoram Harth and Daniel Lischinsky, EndyMed operates with 51–200 employees. The company has raised $7M across two funding rounds, with OHMK Medical Technology as an investor. A significant milestone for EndyMed was its initial public offering on the TASE in January 2007.
Business overview
EndyMed Medical is a medical technology company specializing in the design, development, and commercialization of energy-based aesthetic treatment systems. The company's core technology is its proprietary 3DEEP radio frequency, which is multisource and phase-controlled. This technology provides solutions for fractional skin resurfacing, wrinkle treatment, scar treatment, skin tightening, and body contouring, serving the health tech and life sciences sectors, particularly in medical devices and aesthetic devices.
Strategic signal
In March 2025, EndyMed announced a full merger with its majority shareholder and distributor in China, Shanghai Haohai. This strategic move strengthens EndyMed's global market position, particularly in the significant Chinese market, signaling a deeper integration and commitment to international expansion and market penetration for investors.
Log in to access full profile ›Company Intelligence Q&A
- When was EndyMed founded?
- EndyMed was founded in January 2007 by Yoram Harth and Daniel Lischinsky.
- What was a significant recent corporate development for EndyMed?
- In March 2025, EndyMed announced the successful completion of its full merger with its majority shareholder and distributor in China, aiming to strengthen its global market position.
- What is EndyMed's primary technology?
- EndyMed's primary technology is its proprietary 3DEEP radio frequency technology, which is multisource and phase-controlled, used for various aesthetic treatments.
- What was a notable product launch by EndyMed?
- In February 2019, ENDYMED Medical released the FSR Fractional Skin Resurfacing Treatment Applicator in the US market.
- What was a key distribution agreement for EndyMed?
- In July 2016, EndyMed signed a distribution agreement in South Korea.